Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Cancer stem cell marker CD133+ tumour cells and clinical outcome in rectal cancer.

Wang Q, Chen ZG, Du CZ, Wang HW, Yan L, Gu J.

Histopathology. 2009 Sep;55(3):284-93. doi: 10.1111/j.1365-2559.2009.03378.x.

PMID:
19723143
2.

Prognostic value of cancer stem cell marker CD133 expression in non-small cell lung cancer: a systematic review.

Qu H, Li R, Liu Z, Zhang J, Luo R.

Int J Clin Exp Pathol. 2013 Oct 15;6(11):2644-50. eCollection 2013. Review.

3.

CD133 as a marker for cancer stem cells: progresses and concerns.

Wu Y, Wu PY.

Stem Cells Dev. 2009 Oct;18(8):1127-34. doi: 10.1089/scd.2008.0338. Review.

PMID:
19409053
4.

Research progression of CD133 as a marker of cancer stem cells.

Zhang H, Li SY.

Chin J Cancer. 2010 Mar;29(3):243-7. Review.

5.

CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges.

Grosse-Gehling P, Fargeas CA, Dittfeld C, Garbe Y, Alison MR, Corbeil D, Kunz-Schughart LA.

J Pathol. 2013 Feb;229(3):355-78. doi: 10.1002/path.4086. Epub 2012 Nov 20. Review.

PMID:
22899341
6.

Relevant markers of cancer stem cells indicate a poor prognosis in hepatocellular carcinoma patients: a meta-analysis.

Ma YC, Yang JY, Yan LN.

Eur J Gastroenterol Hepatol. 2013 Sep;25(9):1007-16. doi: 10.1097/MEG.0b013e32836019d8. Review.

PMID:
23478672
7.

The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells.

Bidlingmaier S, Zhu X, Liu B.

J Mol Med (Berl). 2008 Sep;86(9):1025-32. doi: 10.1007/s00109-008-0357-8. Epub 2008 Jun 6. Review.

8.

Prognostic value of cancer stem cell marker CD133 expression in gastric cancer: a systematic review.

Wen L, Chen XZ, Yang K, Chen ZX, Zhang B, Chen JP, Zhou ZG, Mo XM, Hu JK.

PLoS One. 2013;8(3):e59154. doi: 10.1371/journal.pone.0059154. Epub 2013 Mar 22. Review. Erratum in: PLoS One. 2014;9(1). doi:10.1371/annotation/80c50c32-16b8-4099-98e4-af72154192b3.

9.

How powerful is CD133 as a cancer stem cell marker in brain tumors?

Cheng JX, Liu BL, Zhang X.

Cancer Treat Rev. 2009 Aug;35(5):403-8. doi: 10.1016/j.ctrv.2009.03.002. Epub 2009 Apr 14. Review.

PMID:
19369008
10.

Targeting CD133 antigen in cancer.

Ferrandina G, Petrillo M, Bonanno G, Scambia G.

Expert Opin Ther Targets. 2009 Jul;13(7):823-37. doi: 10.1517/14728220903005616. Review.

PMID:
19530986
11.

CD133: molecule of the moment.

Mizrak D, Brittan M, Alison M.

J Pathol. 2008 Jan;214(1):3-9. Review.

PMID:
18067118
12.

What is the clinical value of cancer stem cell markers in gliomas?

Dahlrot RH, Hermansen SK, Hansen S, Kristensen BW.

Int J Clin Exp Pathol. 2013;6(3):334-48. Epub 2013 Feb 15. Review.

13.

Tumour-initiating cells vs. cancer 'stem' cells and CD133: what's in the name?

Neuzil J, Stantic M, Zobalova R, Chladova J, Wang X, Prochazka L, Dong L, Andera L, Ralph SJ.

Biochem Biophys Res Commun. 2007 Apr 20;355(4):855-9. Epub 2007 Feb 6. Review.

PMID:
17307142
14.

Prognostic value of cancer stem cell marker CD133 expression in pancreatic ductal adenocarcinoma (PDAC): a systematic review and meta-analysis.

Li X, Zhao H, Gu J, Zheng L.

Int J Clin Exp Pathol. 2015 Oct 1;8(10):12084-92. eCollection 2015. Review.

15.

CD133: holy of grail of neuro-oncology or promiscuous red-herring?

Donovan LK, Pilkington GJ.

Cell Prolif. 2012 Dec;45(6):527-37. doi: 10.1111/j.1365-2184.2012.00842.x. Review.

PMID:
23106300
16.

Cancer stem cells in the central nervous system--a critical review.

Prestegarden L, Enger PØ.

Cancer Res. 2010 Nov 1;70(21):8255-8. doi: 10.1158/0008-5472.CAN-10-1592. Epub 2010 Oct 19. Review.

17.

CD133 expression and the prognosis of colorectal cancer: a systematic review and meta-analysis.

Chen S, Song X, Chen Z, Li X, Li M, Liu H, Li J.

PLoS One. 2013;8(2):e56380. doi: 10.1371/journal.pone.0056380. Epub 2013 Feb 11. Review.

18.

CD133: a cancer stem cells marker, is used in colorectal cancers.

Ren F, Sheng WQ, Du X.

World J Gastroenterol. 2013 May 7;19(17):2603-11. doi: 10.3748/wjg.v19.i17.2603. Review.

19.

Pancreatic cancer stem cells: their role in pancreatic cancer patient outcomes and what is future?

Habib M, Saif MW.

JOP. 2013 Jul 10;14(4):401-4. doi: 10.6092/1590-8577/1658. Review.

20.

[The role of tyrosine phosphorylation of cancer stem cell marker CD133 in malignant tumor progression].

Shimozato O, Nagase H, Ozaki T.

Seikagaku. 2015 Jun;87(3):389-92. Review. Japanese. No abstract available.

PMID:
26571608

Supplemental Content

Support Center